OXAPROZIN (oxaprozin) by Teva is cyclooxygenase inhibitors [moa]. Approved for rheumatoid arthritis, rheumatoid arthritis, for relief of the signs and symptoms of osteoarthritis. First approved in 2002.
Drug data last refreshed 1w ago
Cyclooxygenase Inhibitors
Drug-drug Interaction Study of FYU-981 and Oxaprozin
Worked on OXAPROZIN at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.